111 related articles for article (PubMed ID: 38382228)
1. Multi-omics analysis-based macrophage differentiation-associated papillary thyroid cancer patient classifier.
Sun H; Chang Z; Li H; Tang Y; Liu Y; Qiao L; Feng G; Huang R; Han D; Yin DT
Transl Oncol; 2024 May; 43():101889. PubMed ID: 38382228
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.
Chen Z; Wang Y; Li D; Le Y; Han Y; Jia L; Yan C; Tian Z; Song W; Li F; Zhao K; He X
Front Oncol; 2022; 12():862313. PubMed ID: 35359404
[TBL] [Abstract][Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma.
Wang T; Shi J; Li L; Zhou X; Zhang H; Zhang X; Wang Y; Liu L; Sheng L
Front Immunol; 2022; 13():840811. PubMed ID: 35515000
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
[TBL] [Abstract][Full Text] [Related]
6. Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma.
Wang B; Li M; Li R
Front Oncol; 2023; 13():1169395. PubMed ID: 37091151
[TBL] [Abstract][Full Text] [Related]
7. Single-cell transcriptomic landscape reveals the differences in cell differentiation and immune microenvironment of papillary thyroid carcinoma between genders.
Peng M; Wei G; Zhang Y; Li H; Lai Y; Guo Y; Chen Y; Liu L; Xiao H; Guan H; Li Y
Cell Biosci; 2021 Feb; 11(1):39. PubMed ID: 33588924
[TBL] [Abstract][Full Text] [Related]
8. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
9. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
10. CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma.
Cho SW; Kim YA; Sun HJ; Kim YA; Oh BC; Yi KH; Park DJ; Park YJ
Endocr Relat Cancer; 2016 Feb; 23(2):113-24. PubMed ID: 26559672
[TBL] [Abstract][Full Text] [Related]
11. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
Wang L; Yao B; Yang J; Tian Z; He J
BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Chen F; Li Z; Deng C; Yan H
J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Chen W; Yu X; Li H; Yuan S; Fu Y; Hu H; Liu F; Zhang Y; Zhong S
Oral Oncol; 2024 Jan; 148():106654. PubMed ID: 38061122
[TBL] [Abstract][Full Text] [Related]
14. Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.
Li M; Zhang J; Zhang Z; Qian Y; Qu W; Jiang Z; Zhao B
Front Endocrinol (Lausanne); 2022; 13():721569. PubMed ID: 35185791
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of fibroblasts molecular features in papillary thyroid cancer combining single-cell and bulk RNA sequencing technology.
Li W; Liu Z; Cen X; Xu J; Zhao S; Wang B; Zhang W; Qiu M
Front Endocrinol (Lausanne); 2022; 13():1019072. PubMed ID: 36387901
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.
Weng D; He L; Chen X; Lin H; Ji D; Lu S; Ao L; Wang S
Front Immunol; 2022; 13():1055412. PubMed ID: 36713370
[TBL] [Abstract][Full Text] [Related]
19. Low expression of
Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J
Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a novel risk model based on CD8T cell marker genes to predict prognosis in thyroid cancer by integrated analysis of single-cell and bulk RNA-sequencing.
Du J; Song CF; Wang S; Tan YC; Wang J
Medicine (Baltimore); 2023 Oct; 102(42):e35192. PubMed ID: 37861558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
